Form 4: GoodRx Director Julie Bradley Reports Acquisition of Class A Common Stock

Julie Bradley, a director at GoodRx Holdings, reported acquiring 28,398 shares of Class A Common Stock on June 6, 2024.

Summary

• On June 6, 2024, Julie Bradley, a director of GoodRx Holdings, Inc., acquired 28,398 shares of Class A Common Stock.
• The acquisition was reported in a Form 4 filing with the SEC.
• Following the transaction, Bradley directly owns 123,653 shares of Class A Common Stock.
• The acquired securities are restricted stock units that vest on the earlier of June 6, 2025, or the date of the 2025 Annual Meeting of Stockholders, contingent upon continued service.

Sentiment

Score: 6

Explanation: Director purchasing stock is generally a positive sign, but the impact is moderate as it's a relatively small transaction and part of a standard compensation package.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 6, 2024 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.

Industry Context

Director stock acquisitions are common and closely watched as indicators of management's sentiment about the company's prospects. This filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The acquisition of shares by a director could positively influence shareholder sentiment.

Key Dates